About five million patients currently suffer from heart failure (HF) in the US, resulting in about one million hospitalizations annually and a yearly cost of over 35 billion USD. The long-term objective of this project is to develop an innovative technology to assist HF outpatient management. The proposed device will be used by ambulatory individuals to alert them and their healthcare providers to deterioration of HF status (e.g., via wireless/cell phone or other methods). This will facilitate early therapeutic intervention, which may result in reduced hospitalization, morbidity, cost and potentially mortality. The technology relies on detecting changes in low-frequency chest wall vibrations due to the physical motion of the heart, blood flow and valves. These sub-audible vibrations can be detected and analyzed with appropriate sensors and digital signal processing methods. The proposed first-generation novel device is not intended for initial diagnosis of HF patients (i.e., distinguishing normal from abnormal subjects);rather it is intended for early ambulatory detection of changes in chest wall vibrations that may be associated with clinical changes in HF individuals. The proposed device would be non-invasive, safe, and require brief measurement time (~ 60 sec). There would not be a need to wear the device constantly. Instead, patients would typically test themselves once daily and as needed. During Phase I, candidate sensors will be tested and a first-generation prototype built. Reproducibility of chest wall vibration signals will be tested in normal and HF subjects. These human studies will help delineate chest vibration correlates of HF status changes. If the project is successful, the proposed novel technology would be used by HF outpatients for self monitoring, for automated remote assessment (e.g. via internet or phone), or as a rapid assessment and monitoring tool during healthcare provider visits. It is expected that the envisioned device would be compact, easy and comfortable to use, rapid, inexpensive and safe.

Public Health Relevance

This project proposes to develop a device to help improve monitoring and treatment of out-patients with heart failure by alerting them and their providers to worsening disease. This will allow improved early therapeutic intervention, which should result in reduced hospitalizations, illness, cost and potentially deaths.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43HL099053-01A1
Application #
8055611
Study Section
Special Emphasis Panel (ZRG1-SSMI-Q (10))
Program Officer
Baldwin, Tim
Project Start
2011-08-17
Project End
2013-07-31
Budget Start
2011-08-17
Budget End
2013-07-31
Support Year
1
Fiscal Year
2011
Total Cost
$339,058
Indirect Cost
Name
Biomedical Acoustics Research Company
Department
Type
DUNS #
035035521
City
Evanston
State
IL
Country
United States
Zip Code
60202
Taebi, Amirtaha; Mansy, Hansen A (2017) Time-Frequency Distribution of Seismocardiographic Signals: A Comparative Study. Bioengineering (Basel) 4:
Taebi, A; Mansy, H A (2016) Effect of Noise on Time-frequency Analysis of Vibrocardiographic Signals. J Bioeng Biomed Sci 6: